Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001213900-25-039184
Filing Date
2025-05-02
Accepted
2025-05-02 16:30:25
Documents
13
Period of Report
2025-04-15
Items
Item 4.02: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review

Document Format Files

Seq Description Document Type Size
1 FORM FORM 8-K/A ea024046901-8ka_abvcbio.htm   iXBRL 8-K/A 22484
  Complete submission text file 0001213900-25-039184.txt   195685

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE abvc-20250501.xsd EX-101.SCH 3029
3 XBRL LABEL FILE abvc-20250501_lab.xml EX-101.LAB 34239
4 XBRL PRESENTATION FILE abvc-20250501_pre.xml EX-101.PRE 22368
15 EXTRACTED XBRL INSTANCE DOCUMENT ea024046901-8ka_abvcbio_htm.xml XML 3676
Mailing Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538
Business Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538 510-668-0881
ABVC BIOPHARMA, INC. (Filer) CIK: 0001173313 (see all company filings)

EIN.: 260014658 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-40700 | Film No.: 25909118
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)